T-cell activation by treatment of cancer patients with EMD 521873 (Selectikine), an IL-2/anti-DNA fusion protein

BACKGROUND: EMD 521873 (Selectikine or NHS-IL2LT) is a fusion protein consisting of modified human IL-2 which binds specifically to the high-affinity IL-2 receptor, and an antibody specific for both single- and double-stranded DNA, designed to facilitate the enrichment of IL-2 in tumor tissue. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Laurent, Julien, Touvrey, Cedric, Gillessen, Silke, Joffraud, Magali, Vicari, Manuela, Bertrand, Caroline, Ongarello, Stefano, Liedert, Bernd, Gallerani, Elisa, Beck, Joachim, Omlin, Aurelius, Sessa, Cristiana, Quaratino, Sonia, Stupp, Roger, Gnad-Vogt, Ulrike S, Speiser, Daniel E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551760/
https://www.ncbi.nlm.nih.gov/pubmed/23294527
http://dx.doi.org/10.1186/1479-5876-11-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551760/
https://www.ncbi.nlm.nih.gov/pubmed/23294527
http://dx.doi.org/10.1186/1479-5876-11-5

Ejemplares similares